JPS5234912A - Extraction of ganglioside and application of same to new medicines - Google Patents

Extraction of ganglioside and application of same to new medicines

Info

Publication number
JPS5234912A
JPS5234912A JP51097402A JP9740276A JPS5234912A JP S5234912 A JPS5234912 A JP S5234912A JP 51097402 A JP51097402 A JP 51097402A JP 9740276 A JP9740276 A JP 9740276A JP S5234912 A JPS5234912 A JP S5234912A
Authority
JP
Japan
Prior art keywords
ganglioside
extraction
application
same
new medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP51097402A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6250450B2 (enrdf_load_stackoverflow
Inventor
Buetsukia Ruiiji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of JPS5234912A publication Critical patent/JPS5234912A/ja
Publication of JPS6250450B2 publication Critical patent/JPS6250450B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP51097402A 1975-08-13 1976-08-13 Extraction of ganglioside and application of same to new medicines Granted JPS5234912A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT26323/75A IT1046051B (it) 1975-08-13 1975-08-13 Nuova applicazione terapeutica dei gangliosidi e procedimento per la loro estrazione

Publications (2)

Publication Number Publication Date
JPS5234912A true JPS5234912A (en) 1977-03-17
JPS6250450B2 JPS6250450B2 (enrdf_load_stackoverflow) 1987-10-24

Family

ID=11219226

Family Applications (2)

Application Number Title Priority Date Filing Date
JP51097402A Granted JPS5234912A (en) 1975-08-13 1976-08-13 Extraction of ganglioside and application of same to new medicines
JP62000347A Granted JPS62187412A (ja) 1975-08-13 1987-01-05 ガングリオシツドの抽出法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP62000347A Granted JPS62187412A (ja) 1975-08-13 1987-01-05 ガングリオシツドの抽出法

Country Status (7)

Country Link
JP (2) JPS5234912A (enrdf_load_stackoverflow)
AT (1) AT352296B (enrdf_load_stackoverflow)
BE (1) BE843695A (enrdf_load_stackoverflow)
DE (1) DE2549680A1 (enrdf_load_stackoverflow)
ES (1) ES441233A1 (enrdf_load_stackoverflow)
FR (1) FR2320760A1 (enrdf_load_stackoverflow)
IT (1) IT1046051B (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222424A (ja) * 1983-06-01 1984-12-14 Katsutaka Nagai 神経障害疾患治療剤
JPS6130521A (ja) * 1984-07-03 1986-02-12 フイデイーア・ソシエタ・ペル・アチオニ 末梢神経障害の疼痛治療用ガングリオシド混合物
JPH0580009A (ja) * 1991-09-20 1993-03-30 Kubota Corp 炭酸濃度測定方法
JPH0580010A (ja) * 1991-09-25 1993-03-30 Kubota Corp 気体中の炭酸ガス濃度測定方法
WO2008096775A1 (ja) * 2007-02-08 2008-08-14 Nippon Zoki Pharmaceutical Co., Ltd. 疼痛疾患治療剤

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2451194A1 (fr) * 1979-03-16 1980-10-10 Merieux Inst Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant
WO1980001875A1 (fr) * 1979-03-16 1980-09-18 Merieux Inst Nouveau medicament, notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant
CA1168980A (en) * 1980-04-17 1984-06-12 Rolf Schafer Wound healing compositions
AU542815B2 (en) * 1980-05-09 1985-03-14 Leffler, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
DE3379656D1 (en) * 1983-05-27 1989-05-24 Shanksville Corp N V Suppressing of graft rejection in organ transplantation
JPH01228997A (ja) * 1988-03-10 1989-09-12 Mect Corp シアロシルグリセライド類及びその製造方法
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
AR241751A1 (es) * 1989-07-12 1992-12-30 Beta Lab Sa Procedimiento para obtener mezclas de gangliosidos para el tratamiento de enfermedades psico-organicas y del caracter.
IT1232176B (it) 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
RU2195296C2 (ru) * 2000-04-12 2002-12-27 Ставропольский научно-исследовательский противочумный институт Способ получения ганглиозидов
RU2192871C2 (ru) * 2000-11-22 2002-11-20 Нижегородское государственное предприятие по производству бактерийных препаратов - ИмБио Способ получения биологически активного комплекса из животного сырья для терапевтического использования

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436413A (en) * 1965-12-21 1969-04-01 Canada Packers Ltd Process for the isolation of phosphatidyl serine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT127981B (de) * 1929-06-07 1932-04-25 Schering Kahlbaum Ag Verfahren zur Herstellung eines die zentralen Tätigkeiten fördernden und regulierenden Reizstoffes.
CH193176A (de) * 1936-12-08 1937-09-30 Richter Arthur Verfahren zur Gewinnung eines Wirkstoffes aus Säugetiergehirn.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436413A (en) * 1965-12-21 1969-04-01 Canada Packers Ltd Process for the isolation of phosphatidyl serine

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222424A (ja) * 1983-06-01 1984-12-14 Katsutaka Nagai 神経障害疾患治療剤
JPS6130521A (ja) * 1984-07-03 1986-02-12 フイデイーア・ソシエタ・ペル・アチオニ 末梢神経障害の疼痛治療用ガングリオシド混合物
JPH0580009A (ja) * 1991-09-20 1993-03-30 Kubota Corp 炭酸濃度測定方法
JPH0580010A (ja) * 1991-09-25 1993-03-30 Kubota Corp 気体中の炭酸ガス濃度測定方法
WO2008096775A1 (ja) * 2007-02-08 2008-08-14 Nippon Zoki Pharmaceutical Co., Ltd. 疼痛疾患治療剤
US8492350B2 (en) 2007-02-08 2013-07-23 Nippon Zoki Pharmaceutical Co., Ltd. Therapeutic agent for pain disease

Also Published As

Publication number Publication date
AT352296B (de) 1979-09-10
JPS6256134B2 (enrdf_load_stackoverflow) 1987-11-24
DE2549680A1 (de) 1977-02-24
ES441233A1 (es) 1977-03-16
FR2320760A1 (fr) 1977-03-11
ATA606976A (de) 1979-02-15
JPS6250450B2 (enrdf_load_stackoverflow) 1987-10-24
DE2549680C2 (enrdf_load_stackoverflow) 1988-05-11
JPS62187412A (ja) 1987-08-15
IT1046051B (it) 1980-06-30
FR2320760B1 (enrdf_load_stackoverflow) 1978-11-17
BE843695A (fr) 1976-11-03

Similar Documents

Publication Publication Date Title
JPS5257176A (en) Production of novel imidazolidine and pharmaceutical composition
PT65554B (en) Laminate and process of its manufacture
GB1546870A (en) Separation of solutions
JPS5234912A (en) Extraction of ganglioside and application of same to new medicines
JPS5231063A (en) Production of novel 17 betaaester of nandrolone and novel pharmaceutical agent containing same with assimirating action
KE2919A (en) Production of long acting insulin preparations
JPS5251367A (en) Production of novel substituted 44aminopyrazole and pharmaceutical agent containing the same
GB1539457A (en) Preparation of d-mannitol
JPS5212118A (en) Production of bicynalhydroester and bicynaldiester
JPS52145510A (en) Extraction of 55methoxysolalen and production of 55hydroxysolalen and its derivative and novel solalen derivative
JPS527999A (en) Production of evrnamenine derivatives and pharmaceutical composition
JPS5273885A (en) Benzopyron derivative and its production and drugs having antiiallergy effect containing same
JPS5223081A (en) 1*44dihydropyridines and application to remedy
JPS5210267A (en) Production of ll pyrogulutamyllll prolineamide and production thereof
JPS525799A (en) Production of indroquinolidine derivative and pharmaceutical composition containing same
ZA761843B (en) Extraction and purification of silver
JPS5212920A (en) Preparation of multicolored tablet
JPS5219623A (en) Nitryle and method of its preparation
JPS5262278A (en) Production of novel imidazole compound and pharmaceutical agent
JPS51128958A (en) Production of novel glycoside and pharmaceutical agent containin same
GR61598B (en) Disubstituted phenolethers of 3-amino-2-hydroxypropan,preparation process thereof and use thereof as medicines
PH10333A (en) 6-substituted 3-carbethoxyhydrazinopyridazines and method of preparation thereof
JPS5217488A (en) Production of novel pentacyclic derivative and medicine containing same as effective component
JPS51122008A (en) Dimercaptoethylether derivative preparation method and medicine containing same
JPS5223028A (en) Preparation of alpha* alpha* alpha** alpha** alphaapentachlorooooxylol